article thumbnail

Novo Nordisk forges close ties with biotech VC Flagship

pharmaphorum

That was the thinking applied to the formation of Moderna, which paid off spectacularly with its COVID-19 vaccine, used around the world to fight the pandemic, as well as its rapidly expanding pipeline of additional therapeutics. The move follows Novo Nordisk’s $3.3

article thumbnail

2020 review – Pharma’s progress outside of COVID-19

pharmaphorum

It has been a year dominated by the pandemic and many life sciences research projects were put on hold as big pharma turned its attention to vaccines and therapies. But there was some considerable progress in other fields of medicine even though research efforts were diverted away, reports Richard Staines. Rare disease progress.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The trends driving ELRIG Drug Discovery 2022

Drug Discovery World

One of the main sessions at this year’s event will look back on how the collaboration between Oxford University and AstraZeneca was crucial to the development and manufacture of their Covid-19 vaccine. Knockout’ mice are bred in a laboratory with specific genes silenced or ‘knocked out’.

article thumbnail

World RNA Day: What impact RNA it had on drug discovery?  

Drug Discovery World

As reported by DDW , the aim for the centre is to help future-proof the UK against emerging health threats and the first mRNA vaccine is expected to be produced in the UK in 2025. This Phase I trial will test the experimental vaccine, known as H1ssF-3928 mRNA-LNP, for safety and its ability to induce an immune response.

RNA 52
article thumbnail

RNA Therapeutics: A Novel Approach to Treating Diseases

Roots Analysis

RNA interference (RNAi) Therapeutics : Fundamentally, RNAi is a natural process of post-transcriptional gene silencing, involving short strands of nucleic acids. Cells use this process to silence and / or inhibit gene expression, via targeted degradation of specific (unwanted) mRNA molecules.

RNA 40